Product Information
VENLAFAXINE HCL 25 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0738 per EA under NDC 57237017201. Its NADAC has been published 441 times since Mar 14, 2018.
FDA first approved this application on Apr 7, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237017201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090555FDA Approved
4/7/2010
TE Code
AB
On Market Since
4/7/2010
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL 25 MG TABLET has been published 441 times since Mar 14, 2018, and over the history we have for it it has declined 65.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0738 per EA |
|---|---|
| All-time high | $0.2694 (Sep 11, 2019) |
| All-time low | $0.0488 (Jul 17, 2024) |
| 52-week high | $0.0835 |
| 52-week low | $0.0558 |
| Median price | $0.0987 |
| Average price | $0.1262 |
| Largest weekly change | +94.5% (Aug 19, 2020) |
| Weeks tracked | 441 |
| Tracking since | Mar 14, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL 25 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0738 per EA (NDC 57237017201), effective Aug 19, 2026.
How has the price of VENLAFAXINE HCL 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL 25 MG TABLET has declined 65.0%. It has been tracked across 441 weekly CMS publications since Mar 14, 2018.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL 25 MG TABLET?
Since Mar 14, 2018, the NADAC for VENLAFAXINE HCL 25 MG TABLET has ranged from a low of $0.0488 (Jul 17, 2024) to a high of $0.2694 (Sep 11, 2019), with a median of $0.0987 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL 25 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as VENLAFAXINE HCL 25 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures VENLAFAXINE HCL 25 MG TABLET?
VENLAFAXINE HCL 25 MG TABLET (NDC 57237017201) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.